Topicals represent 5.1% of total prescriptions and 14% of total drug cost, and are being prescribed as an alternative to some oral medications. Within this class, cost drivers including prescription (Rx) and private label topical analgesics (PLTAs) are associated with limited clinical efficacy and exorbitant pricing that often eliminates them as a favorable first-line therapy option. These and other challenges call for careful oversight that includes identification, clinical review and intervention, and/or recommendation of therapeutic alternatives where appropriate to help control inappropriate utilization and spend. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Ask The Pharmacist: Understanding Skeletal Muscle Relaxants in Workers' Compensation
What should I know about skeletal muscle relaxants in the treatment of injuries? Skeletal muscle relaxants a
Workers' Comp
Podcast
Demystifying the Nuances of Specialty Bill Review Regulations
Workers' Comp
Article
Safeguarding Medicare's Interests: Strategies and Updates
With increasing regulations surrounding Medicare compliance, it is critical for claims professionals to stay up-to-date on the latest Medicare Set-
Workers' Comp
Case Study
Utilizing Medical Insights to Strengthen Settlement Accuracy on High-Stakes Claims
Mitchell
News Release
Mitchell’s Debbie Day Wins 2024 Top Tech Executive of the Year Award
SAN DIEGO, Calif.—Mitchell, an Enlyte company and leading technology and information provider for the
Mitchell
Conference
NTHECC 2024 Fall Convention
The National Truck and Heavy Equipment Claims Council (NTHECC) is bringing its Fall Convention to Oklahoma City, where auto insurers and collision